CHALFONT, PA--(Marketwired - February 26, 2014) - Genomind, a personalized medicine company, presented data strongly supporting the utility of pharmacogenomic testing in improving outcomes for psychiatric patients, using their Genecept Assay. Response rates exceeded those reported in the seminal STAR*D trial for patients with depression.
Help employers find you! Check out all the jobs and post your resume.
